Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
Nächste SlideShare
Strategic Analysis - Sanofi Aventis
Weiter
Herunterladen, um offline zu lesen und im Vollbildmodus anzuzeigen.

6

Teilen

SWOT Analysis of Sanofi

Herunterladen, um offline zu lesen

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales

Ähnliche Bücher

Kostenlos mit einer 30-tägigen Testversion von Scribd

Alle anzeigen

Ähnliche Hörbücher

Kostenlos mit einer 30-tägigen Testversion von Scribd

Alle anzeigen

SWOT Analysis of Sanofi

  1. 1. SANOFI BECAUSE HEALTH MATTERS By Lakshmi Ananth JobinThomas
  2. 2. HISTORY & LEGACY • Founded in 1956 4pas Hoechst Fedco Pharma pvt. Limited. • Merged with Roussel India Limited in 1997 to form Hoechst Marion Roussel Limited. • Globally acquired Aventis in 2001 and rebranded as Sanofi (in May 2011) Subsidiary Company Main Operation Sanofi Pasteur (from 1996) Vaccine division Shantha Biotechnics (from 1993) Biotech company for research in rare diseases Genzyme (from 2011) Recombinant health care products Chattem (from 2010) OTC products Zentiva Generic products Medley Contract Manufacturing Nichi-Iko & Merial Generic products
  3. 3. Major Therapeutic Areas • Cardiovascular Diseases • Thrombosis • Diabetes • Internal Medicine • Veterinary Medicines • Central Nervous System • Oncology • Arthritis and Osteoporosis • Consumer Health Care Due to world-class R&D pipeline, Sanofi India has leading positions in the following major therapeutic areas:
  4. 4. SWOT Analysis STRENGTHS • Fourth largest company by prescription sales • Market leadership in vaccines with Sanofi Pasteur • Oncology pipeline has more than 15 molecules. • Usage of renewable energy for manufacturing site • Very good in conducting Social Responsibilities like tuberculosis awareness programmes, diabetes awareness programmes etc., OPPURTUNITIES • Can capture entire African Market and expansion to new geographical areas. • Genzyme has given its considerable presence in uncommon diseases. • Population growth and increase of purchasing power of developing countries. • Marketing agreements with leading companies in developing and developed countries.
  5. 5. SWOT Analysis WEAKNESS • Employee generated lot of negative publicity for company. • Very small business units (Only 2 business units in Goa & Anklaleswar). • Patent expiry of most of blockbuster drugs (Plavix® and Lovenox®). • Low R&D productivity. THREATS • Global economic slowdown as major of company’s revenue is based on Exports. • Chance of losing market because of quality Issues (Combiflam® withdrawal in May 2016). • Stringent regulations in new drug development. • Increase in generic competition.
  6. 6. LITERATURE & RESOURCES • Sanofi India Official Website(http://www.sanofi.in/) • Statement on the recall of Combiflam® batches, May 23rd 2016. • Financial Results for the Q1, June 30, 2016. • Zentiva International Website(http://www.zentiva.com/) • Shantha Biotechnics Website (http://shanthabiotech.com/) • Sanofi Genzyme Website (https://www.sanofigenzyme.com/)
  7. 7. ThankYou.! BECAUSE HEALTH MATTERS SANOFI
  • AnasBoualam

    Jan. 24, 2020
  • SouadTouaf

    Jan. 22, 2020
  • AbhishekKutleheria

    Sep. 16, 2019
  • AudreyLowHong

    Apr. 24, 2018
  • SouhaAyoub1

    Mar. 29, 2018
  • enjyelamir

    Oct. 27, 2017

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales

Aufrufe

Aufrufe insgesamt

5.199

Auf Slideshare

0

Aus Einbettungen

0

Anzahl der Einbettungen

29

Befehle

Downloads

105

Geteilt

0

Kommentare

0

Likes

6

×